Insulin status differentially affects energy transduction in cardiac mitochondria from male and female rats

Diabetes, Obesity and Metabolism

Volumn 8, Issue 1, 2006, Pages 67-74

  Billimoria, Framroze R ^a   Katyare, Surendra S ^b   Patel, Samir P ^b  

^a Terna Medical College   (India)

^b M S UNIVERSITY OF BARODA   (India)

Author keywords

Cytochrome profiles in diabetes; Dehydrogenases in diabetes; Diabetes and cardiac mitochondrial function; Diabetic sexual dimorphism in heart mitochondria; STZ diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CYTOCHROME B; CYTOCHROME C; CYTOCHROME C OXIDASE; CYTOCHROME C1; GLUTAMATE DEHYDROGENASE; GLUTAMIC ACID; ISOPHANE INSULIN; MALATE DEHYDROGENASE; MALIC ACID; OXIDOREDUCTASE; PYRUVIC ACID; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN; SUCCINATE DEHYDROGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG DOSE REGIMEN; ENERGY METABOLISM; ENZYME ANALYSIS; ENZYME INHIBITION; FEMALE; HEART MITOCHONDRION; HEART WEIGHT; HIGH RISK PATIENT; INSULIN TREATMENT; ISCHEMIC HEART DISEASE; MALE; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY; RAT; SEX DIFFERENCE; STREPTOZOCIN DIABETES;

EID: 33645993617     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2005.00470.x     Document Type: Article

References (41)

1. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: The Framingham study. Am J Cardiol 1974; 34: 29-34.
2. Pyorala K. Diabetes and coronary heart disease. Acta Endocrinol 1985; 272: 11-19.
3. Regan TJ. Congestive heart failure in the diabetic. Annu Rev Med 1983; 34: 161-168.
4. Feuvray D. Diabetic cardiomyopathy. Arch Mal Coeur Vaiss 2004; 97: 261-265.
5. El-Atat FA, McFarlane SI, Sowers JR, Bigger JT. Sudden cardiac death in patients with diabetes. Curr Diab Report 2004; 4: 187-193.
6. Scognamiglio R, Avogaro A, Negut C, Piccolotto R, Vigili de Kreutzenberg S, Tiengo A. Early myocardial dysfunction in the diabetic heart: Current research and clinical applications. Am J Cardiol 2004; 93: 17A-20A.
7. Spinar J, Vitovec J. Diabetes mellitus and chronic heart failure. Vnitr Lek 2004; 93: 927-934.
8. Avogaro A, Vigili de Kreutzenberg S, Negut C, Tiengo A, Scognamiglio R. Diabetic cardiomyopathy: A metabolic perspective. Am J Cardiol 2004; 93: 13A-16A.
9. Wang Z, Hoy WE. Association between diabetes and coronary heart disease in Aboriginal people: Are women disadvantaged? Med J Aust 2004; 180: 508-511.
10. Axelrod L. Response of congestive heart failure to correction of hyperglycemia in the presence of diabetic nephropathy. N Engl J Med, 1975; 293: 1243-1245.
11. Uusitupa M. Coronary heart disease and left ventricular performance in newly diagnosed non-insulin-dependant diabetics. Finland, University of Kuopio, (MD Dissertation), 1983.
12. McNeill JH, Tahiliani AG. Diabetes-induced cardiac changes. TIPS 1986; 7: 364-367.
13. Sowers JR, Frohlich ED. Insulin and insulin resistance: Impact on blood pressure and cardiovascular disease. Med Clin North Am 2004; 88 (1): 63-82.
14. Airaksinen KE, Koivikko ML, Niemela MJ, Tahvanainen KU, Linnaluoto M, Huikuri HV. Diabetes and haemodynamic reactions to acute coronary occlusion. Int J Cardiol 2004; 95: 237-244.
15. Klein L, Gattis WA, Borrello F, Wu E, O'Connor CM, Gheorghiade M. Effects of amino acid supplementation on left ventricular remodeling in patients with chronicheart failure with decreased systolic function and diabetes mellitus: Rationale and design of a magnetic resonance imaging study. Am J Cardiol 2004; 93: 44A-46A.
16. Fragasso G, Palloshi A, Bassanelli G, Steggerda R, Montano C, Margonato A. Heart disease and diabetes: From pathophysiology to therapeutic options. Ital Heart J 2004; 5 (Suppl. 2): 4S-15S.
17. Nerurkar MA, Satav JG, Katyare SS. Insulin dependent changes in cathepsin D activity in rat liver, kidney, brain and heart. Diabetologia 1988; 31: 119-122.
18. Parks WC, Drake RL. Insulin mediates the stimulation of pyruvate kinase by a dual mechanism. Biochem J, 1982; 208: 333-337.
19. Bittner DL, Manning J. In: Automation in Analytical Chemistry. Technicon Symposia, Vol. 1. New York: White Plains, 1967, 33.
20. Doussiere J, Ligeti E, Brandolin G, Vignais PV. Control of oxidative phosphorylation in rat heart mitochondria. The role of adenine nucleotide carrier. Biochen Biophys Acta 1984; 766: 492-500.
21. Katyare SS, Rajan RR. Altered energy coupling in rat heart mitochondria following in vitro treatment with propranolol. Biochem Pharmacol 1991; 42: 617-623.
22. Katewa SD, Katyare SS. Treatment with antimalarials adversely affects the oxidative energy metabolism in rat liver mitochondria. Drug Chem Toxicol 2004; 27: 43-55.
23. Subramaniam M, Katyare S15S. Oxidative phosphorylation in mouse liver mitochondria during weaning. Mech Ageing Dev 1990; 54: 121-129.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
25. Cohen MP. Diabetes and protein glycosylation. In: Measurement and Biological Relevance, New York: Springer 1986, 1-40.
26. Belfiore F, Molinatti GM, Reaven GM. Metabolism of glomerular basement membrane in diabetes. In: Tissue-Specific Metabolic Alterations in Diabetes. Front Diabetes. Vol. 10. Basel: Karger, 1990, 61-77.
27. Podlesny M. Diabetic cardiomyopathy. Pol Merkuriusz Lek 2003; 15: 476-479.
28. Harrower AD, Clarke BF. Experience of coronary care in diabetes. Br Med J 1976; 1: 126-128.
29. Alberti KGMM, Press CM. The biochemistry of the complications of diabetes mellitus. In: Keen M, Jarrett J, eds. Complications of Diabetes. London: Edward Arnold Ltd, 1982, 231-270.
30. Ido Y, Vindigni A, Chang K et al. Prevention of vascular and neuronal dysfunction in diabetic rat by C-peptide. Science 1997; 277: 563-566.
31. Steiner DE, Rubenstein AM. Proinsulin C-peptide - Biological activity? Science 1997; 277: 531-532.
32. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527-605.
33. Halliwell B, Gutteridge JMC. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984; 219: 1-14.
34. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992; 59: 1609-1623.
35. Wallace DC. Animal models for mitochondrial disease. Meth Mol Biol 2002; 197: 3-54.
36. Akhilashwar V. The role of reactive oxygen species (ROS) in diabetic Cardiomyopathy in male and female diabetic rats: A comparative study. M. S. University of Baroda, (MSc Dissertation), 2002.
37. Ye G, Metreveli NS, Donthi RV et al. Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 2004; 53: 1336-1343.
38. Brignone JA, Campos de Brignone CM, Rodriguez RR, Badano BN, Stoppani AOM. Modified oscillation behavior and decreased D-3-hyroxybutyrate dehydrogenase activity in diabetic rat liver mitochondria. Arch Biochem Biophys 1982; 214: 581-588.
39. Reinhart RW, Roberson J, Beattie D. The effect of diabetes on protein synthesis and the respiratory chain of rat skeletal muscle and kidney mitochondria. Arch Biochem Biophys 1987; 213: 341-352.
40. Katyare SS, Satav JG. Effect of streptozotocin-induced diabetes on oxidative energy metabolism in rat kidney mitochondria, A compatative study of early and late effects. Diabetes Obes Metab 2004; doi:10.1111/ J.1463-1326.2004.00470.x
41. Kuo TH, Moore KH, Giacomelli F, Wiener J. Defective oxidative metabolism of heart mitochondria from genetically diabetic mice. Diabetes 2004; 32: 781-787.